The Multi-Drug/Combination Injectable Market is projected to grow from USD 32.0 billion in 2025 to USD 62.9 billion by 2035, at a CAGR of 7.0%. Metabolic/Obesity & Diabetes will dominate with a 40.0% market share, while autoinjector/pen will lead the delivery form segment with a 36.0% share.